Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 38,964 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

38,964 Papers indexed
963 Papers AI scored
38,964 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.

LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

38964 results
C
Evaluation of the Mechanical Failure of Noninvasive Expandable Prostheses: A Retrospective Service Evaluation of a UK Health Service.
PMID 42526912 Published: 2026-06-01 Ingested: 2026-08-02 12:07 AM Journal of pediatric orthopedics
AI -
Standard 62.7
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 62.7/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 21.0; sample size: 50.0; recency: 100.0; abstract quality: 100.0.

C
Pathologic Misclassification of Renal Cell Carcinoma in Adolescents and Young Adults.
PMID 42449566 Published: 2026-06-23 Ingested: 2026-08-02 12:07 AM Cancers
AI -
Standard 62.7
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 62.7/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 16.0; sample size: 60.0; recency: 100.0; abstract quality: 100.0.

C
Primary intracranial sarcomas in Peruvian children: a high-incidence clinicopathological series from a National Reference Center.
PMID 42428815 Published: 2026-05-27 Ingested: 2026-08-02 12:06 AM Ecancermedicalscience
AI -
Standard 62.7
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 62.7/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 16.0; sample size: 60.0; recency: 100.0; abstract quality: 100.0.

C
AI -
Standard 62.7
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 62.7/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 21.0; sample size: 50.0; recency: 100.0; abstract quality: 100.0.

C
AI -
Standard 62.7
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 62.7/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 16.0; sample size: 60.0; recency: 100.0; abstract quality: 100.0.

AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 62.7/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 36.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

C
AI -
Standard 62.7
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 62.7/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 36.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

C
Incidence trends, outcomes, and factors associated with mortality in multisystem inflammatory syndrome in children: A nationwide study in Thailand during 2021-2023.
PMID 42102901 Published: 2026-05-06 Ingested: 2026-08-02 12:06 AM International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
AI -
Standard 62.7
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 62.7/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 16.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
AI -
Standard 62.7
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 62.7/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 16.0; sample size: 60.0; recency: 100.0; abstract quality: 100.0.

C
AI -
Standard 62.7
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 62.7/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 21.0; sample size: 50.0; recency: 100.0; abstract quality: 100.0.

C
Radiologic examinations in pregnancy: a critical appraisal of radiation and contrast risks.
PMID 42091463 Published: 2026-05-06 Ingested: 2026-08-02 12:06 AM The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
AI -
Standard 62.7
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 62.7/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 16.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
Current management of low-grade, epilepsy-associated brain tumors in Europe.
PMID 42080219 Published: 2026-05-04 Ingested: 2026-08-02 12:07 AM Epilepsia
AI -
Standard 62.7
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 62.7/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 36.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

Previous
Page 1413 of 3247
Next
Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic